I assess the impact that pharmaceutical innovation had on cancer mortality in Mexico during the period 2003–2013, by ….) that were subject to more pharmaceutical innovation, controlling for changes in the age-standardized cancer incidence rate … of cancer drug innovation to Mexican longevity growth has been valuable, but, perhaps, it could have been even larger …

, expected survival, number of people diagnosed, and innovation in diagnostic, radiation, and surgical procedures. We find that …